Correlation Between Sinphar Pharmaceutical and Grape King

Can any of the company-specific risk be diversified away by investing in both Sinphar Pharmaceutical and Grape King at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sinphar Pharmaceutical and Grape King into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sinphar Pharmaceutical Co and Grape King Bio, you can compare the effects of market volatilities on Sinphar Pharmaceutical and Grape King and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sinphar Pharmaceutical with a short position of Grape King. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sinphar Pharmaceutical and Grape King.

Diversification Opportunities for Sinphar Pharmaceutical and Grape King

-0.06

Correlation Coefficient

Sinphar Pharmaceutical  Grape King

Good diversification

The 3 months correlation between Sinphar and Grape is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Sinphar Pharmaceutical Co and Grape King Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Grape King Bio and Sinphar Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sinphar Pharmaceutical Co are associated (or correlated) with Grape King. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Grape King Bio has no effect on the direction of Sinphar Pharmaceutical i.e., Sinphar Pharmaceutical and Grape King go up and down completely randomly.

Pair Corralation between Sinphar Pharmaceutical and Grape King

Assuming the 90 days trading horizon Sinphar Pharmaceutical Co is expected to under-perform the Grape King. In addition to that, Sinphar Pharmaceutical is 1.47 times more volatile than Grape King Bio. It trades about -0.08 of its total potential returns per unit of risk. Grape King Bio is currently generating about -0.02 per unit of volatility. If you would invest  15,200  in Grape King Bio on October 7, 2024 and sell it today you would lose (500.00) from holding Grape King Bio or give up 3.29% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Sinphar Pharmaceutical Co  vs.  Grape King Bio

Sinphar Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sinphar Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Sinphar Pharmaceutical is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Grape King Bio

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Grape King Bio are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Grape King is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Sinphar Pharmaceutical and Grape King

The main advantage of trading using opposite Sinphar Pharmaceutical and Grape King positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sinphar Pharmaceutical position performs unexpectedly, Grape King can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Grape King will offset losses from the drop in Grape King's long position.

The idea behind Sinphar Pharmaceutical Co and Grape King Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.